title: Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus.
abstract: Identification of compounds preventing or modifying the biochemical changes that underlie the epileptogenesis process and understanding the mechanism of their action are of great importance. We have previously shown that myoinositol (MI) daily treatment for 28 days prevents certain biochemical changes that are triggered by kainic acid (KA) induced status epilepticus (SE). However in these studies we have not detected any effects of MI on the first day after SE. In the present study we broadened our research and focused on other molecular and morphological changes at the early stages of SE induced by KA and effects of MI treatment on these changes. The increase in the amount of voltage-dependent anionic channel-1 (VDAC-1), cofilin, and caspase-3 activity was observed in the hippocampus of KA treated rats. Administration of MI 4 hours later after KA treatment abolishes these changes, whereas diazepam treatment by the same time schedule has no significant influence. The number of neuronal cells in CA1 and CA3 subfields of hippocampus is decreased after KA induced SE and MI posttreatment significantly attenuates this reduction. No significant changes are observed in the neocortex. Obtained results indicate that MI posttreatment after KA induced SE could successfully target the biochemical processes involved in apoptosis, reduces cell loss, and can be successfully used in the future for translational research.
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia.
authors.forename: Lia
authors.identifier: 0000-0001-5545-8009
authors.initials: L
authors.lastname: Tsverava
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia; I. Beritashvili Center of Experimental Biomedicine, 14 L. Gotua Street, 0160 Tbilisi, Georgia.
authors.forename: Tamar
authors.identifier: 0000-0002-5567-2678
authors.initials: T
authors.lastname: Lordkipanidze
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia.
authors.forename: Eka
authors.identifier: 0000-0001-8991-4666
authors.initials: E
authors.lastname: Lepsveridze
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia; I. Beritashvili Center of Experimental Biomedicine, 14 L. Gotua Street, 0160 Tbilisi, Georgia.
authors.forename: Maia
authors.identifier: 0000-0002-7713-5945
authors.initials: M
authors.lastname: Nozadze
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia.
authors.forename: Marina
authors.initials: M
authors.lastname: Kikvidze
authors.affiliation: Institute of Chemical Biology, Ilia State University, 3/5 K. Cholokashvili Avenue, 0162 Tbilisi, Georgia; I. Beritashvili Center of Experimental Biomedicine, 14 L. Gotua Street, 0160 Tbilisi, Georgia.
authors.forename: Revaz
authors.identifier: 0000-0003-4798-6762
authors.initials: R
authors.lastname: Solomonia
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002138:Calibration; D053148:Caspase 3 / Q000378:metabolism; D002452:Cell Count; D006624:Hippocampus / Q000473:pathology; D007294:Inositol / Q000494:pharmacology* / Q000627:therapeutic use*; D007608:Kainic Acid; D008297:Male; D051336:Mitochondrial Membranes / Q000187:drug effects / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D017208:Rats, Wistar; D013226:Status Epilepticus / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D009419:Nerve Tissue Proteins; D007294:Inositol; D053148:Caspase 3; D007608:Kainic Acid